(Q74579820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

title

Leukotriene receptor antagonist treatment of asthma: are we there yet? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

C M Kercsmar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

256-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Effect of long-term salmeterol treatment on exercise-induced asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Attained adult height after childhood asthma: effect of glucocorticoid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970444-0

10.1016/S0022-3476(99)70444-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10064656%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference